The Institut Pasteur is a scientific partner of Argobio Studio, a French start-up studio aiming at creating at least five ambitious therapeutic biotech spinouts over the next five years. Argobio will incubate early-stage, highly innovative therapeutic projects up to company creation and Series A venture funding in selected therapeutic areas.
Prof. Stewart Cole, CEO of the Institut Pasteur, said: "The Institut Pasteur as a strategic and scientific partner is pleased to participate to the creation of Argobio and to the value creation dynamics Argobio aspires to. In 2019, we have set up the Pasteurian Innovation Accelerator (PIA) to increase the development potential of our research applications: we are focusing our efforts on flagship projects certified by an independent committee. The investment of the Institut Pasteur and the close collaboration between PIA and Argobio are fully in line with this strategy”.